FDA Warning Letter — Bellingham IVF & Fertility Care
The FDA took a Warning Letter action against Bellingham IVF & Fertility Care on May 7, 2018 (Bellingham, WA). The action was issued by CBER and concerns biologics products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Bellingham IVF & Fertility Care
- Date
- May 7, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Center
- CBER
- Location
- Bellingham, WA (United States)